Mediclinic International plc
Mediclinic International plc (ANHGY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
anhgy · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Mediclinic International plcYou ANHGY | $4.0B | 26.27x | +30.5% | $0.20 |
 Alfresa Holdings Corporation ARHCF | $2.2B | 8.15x | -59.5% | $231.09 |
 Ascentage Pharma Group International ASPHF | $1.7B | N/A | — | -$3.40 |
 McKesson Europe AG CAKFY | $5.4B | N/A | — | -$0.05 |
 Dechra Pharmaceuticals PLC DCHPF | $5.3B | N/A | — | -$0.25 |
 Galenica AG GALNF | $5.7B | 25.35x | +25.9% | $3.63 |
 Hangzhou Tigermed Consulting Co., Ltd. HNGZY | $6.2B | 26.89x | +33.6% | $1.04 |
Industry Average 3 peers with valid PE | — | 20.13x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Mediclinic International plc (ANHGY) measures how much investors pay for each dollar of the company's trailing earnings. ANHGY's current PE ratio of 26.27x is calculated by dividing its stock price of $5.49 by its TTM earnings per share of $0.20.
Frequently asked questions
ANHGY pe ratio · 6 questionsANHGY's current PE ratio is 26.27x as of 2026-06-09, based on a stock price of $5.49 and TTM EPS of $0.20. Data sourced from Financial Modeling Prep via ANHGY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Mediclinic International plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09